by John Conrad | Jun 27, 2024 | Policy News
In a significant move to address longstanding issues of underrepresentation in medical research, the U.S. Food and Drug Administration (FDA) has released a draft guidance document aimed at increasing diversity in clinical trials. This much-anticipated guidance, titled...
